Latest Cancer Survivorship Programs News

Page 1 of 1

ImpediMed Doubles US Sales, Unlocks $5M Growth Capital Tranche

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Ada Torres

16 July 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026

Top